Cannabis Legislation in Switzerland — The Complete 2026 Legal Guide

The BetmG — The Foundation of Swiss Drug Law

Since 1951, the Narcotics Act (BetmG) has regulated the handling of controlled substances in Switzerland. Cannabis (specifically, hemp flowers with more than 1% total THC) falls under this law. In practice, this means that cultivation, trade, and possession of significant quantities are prohibited and punishable without authorization.

In 2013, the offense of consumption was decriminalized: adults possessing up to 10g of cannabis can be issued an administrative fine (CHF 100) instead of facing criminal prosecution — though cantonal enforcement varies. Selling, possessing larger quantities, and cultivation remain punishable offenses.

The current legal situation is therefore not a complete "legalization", but rather a differentiated system of prohibitions, exceptions, and controlled liberalizations — which we explore below.

The 1% CBD Rule — Why Switzerland is Europe's Most Liberal Market

Hemp products with less than 1% total THC do not fall under the BetmG. Consequently, CBD sale, possession, and consumption are legal — sales are restricted to adults aged 18 and over, with tobacco tax applied to smokable products (flowers, pre-rolls) and general food/cosmetics regulations governing other product types.

By comparison: Germany has a 0.2% THC limit, France 0.3%, and Austria 0.3%. The Swiss 1% limit is significantly more liberal and is the primary reason why a distinct legal market has flourished here since 2017.

Important: The Swiss 1% rule only applies within Switzerland. Taking CBD products abroad means you are subject to local limits — which can quickly lead to legal issues in Germany, Italy, or France.

The Medical Reform of 1 August 2022 — What Has Changed

Before August 2022: Every prescription containing THC required an individual exceptional permit from the Federal Office of Public Health (FOPH). The administrative burden was a major deterrent; only a few hundred patients per year were able to access medical cannabis.

Since 1 August 2022: Licensed Swiss physicians can prescribe cannabis without FOPH approval, just like other prescription medicines. Pharmacies source from legal suppliers and dispense them via standard prescriptions. Full-spectrum extracts (e.g., full-spectrum oil 10 mg/ml) and flowers are readily available.

Impact: Prescription numbers have risen sharply, a professional telemedicine ecosystem has emerged, and general practitioners are cautiously adopting the practice. Details: /de/blog/cannabis-gesetz-schweiz-2022, /de/cannabis-rezept-schweiz.

Cannabis Pilot Projects — The Cantonal Testing Ground

Based on a legal amendment passed in 2021 (the "experimental clause" in the BetmG), cantons are permitted to conduct scientifically monitored pilot projects for the regulated sale of THC to adults. Participants are registered, products are quality-controlled, and sales take place through designated outlets (e.g., pharmacies, licensed dispensaries, or social club structures).

Active or announced projects in 2026 (non-exhaustive): "Weed Care" in Basel-Stadt, the Zurich study, the Bern pilot, and the Lausanne project; other cities are developing their own programs.

Politically, this is the most crucial testing ground: Does regulated supply lead to a smaller black market, better youth protection metrics, and tolerable public health outcomes? The findings will directly shape the ongoing BetmG revision. Detail: /de/blog/cannabis-pilotprojekte-schweiz.

HHC, Synthetic Cannabinoids, and "Grey Area" Substances

Hexahydrocannabinol (HHC) emerged on the Swiss market around 2022 as a CBD-like, mildly psychoactive product. Through an amendment to the narcotics ordinance in 2024, HHC and several related substances were placed under the BetmG — making their sale, manufacture, and trade illegal.

The lesson: Swiss authorities react swiftly to new synthetic cannabinoids. Businesses that attempted to build models around these "grey area" substances are either out of the market or legally exposed in 2026. Reputable Swiss providers stick strictly to CBD derived from natural hemp with <1% THC.

The BetmG Revision — What is Being Discussed

Parliament has been debating a revision of the BetmG regarding cannabis for several years. Key points under discussion include: regulated sales to adults through licensed outlets, taxation models, youth protection measures, advertising bans, limits on THC content in specific products, and social club models inspired by the Spanish system.

The reality in 2026: There is no finalized bill yet, but there is a growing political consensus that the current hybrid situation — consisting of a de facto black market for THC and a liberal CBD market — cannot be the permanent state. Data from the pilot projects over the next 24 months will be decisive.

Penalties and Risks — What Actually Happens

Consumption offense (adult, possession of up to 10g of THC cannabis): Administrative fine of CHF 100, though cantonal enforcement varies.

Possession of larger quantities, sale, or cultivation without a permit: Fines or imprisonment, with significantly harsher penalties for commercial-scale operations.

CBD products exceeding 1% THC without a permit: Treated as THC cannabis, carrying the same legal consequences.

Synthetic cannabinoids (HHC since 2024): Treated exactly like THC cannabis.

Shipping from abroad with THC content: Customs seizure combined with criminal prosecution.

In practice: Those who stay within the legal CBD limit of under 1%, work with Swiss producers, and enforce 18+ age verification are on safe ground. Anyone pushing the boundaries or importing from third countries risks legal action.

Advertising, Packaging, and Sales Regulations

Smokable CBD products are subject to tobacco tax and an advertising framework similar to tobacco (restrictions on outdoor advertising, youth protection). CBD food products fall under food law — health claims are strictly regulated.

Age verification (18+) is the industry standard and effectively mandatory. Reputable providers document this during onboarding (ID upload) and upon delivery (Swiss Post with age verification for relevant products).

International Context — Why Switzerland is a Special Case

In a European comparison, Switzerland combines three characteristics that rarely appear together: a highly liberal CBD limit (1%), a pragmatic medical reform, and a genuine pilot project phase for regulated THC sales. While Germany introduced its own restricted adult access model in 2024, the Swiss approach remains more data-driven and cantonally fine-grained.

Those operating in the Swiss market benefit from this pragmatic stance. Consumers here navigate a legal framework that is noticeably more liberal than in most neighboring EU countries.

Practical Tips for Consumers

Stay within the 1% rule and purchase from Swiss providers with a registered office in Switzerland who provide transparent CoAs.

Avoid synthetic cannabinoids (HHC and similar) — Switzerland closed this market in 2024, and it was never a safe choice for health anyway.

For medical treatment: Consult licensed Swiss physicians, use pharmacies, or utilize specialized telemedicine. Avoid buying via Instagram "prescriptions" from abroad.

Do not take products abroad without clear legal clarification — the Swiss 1% rule only applies domestically.

If you wish to access regulated THC: Check if a pilot project is running in your canton of residence and whether you are eligible to participate.

FAQ